105 related articles for article (PubMed ID: 38951902)
1. Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans.
Bergmans RS; Wegryn-Jones R; Klida C; Kurtz V; Thomas L; Williams DA; Clauw DJ; Kidwell KM; Bohnert ASB; Boehnke KF
BMC Complement Med Ther; 2024 Jun; 24(1):250. PubMed ID: 38951902
[TBL] [Abstract][Full Text] [Related]
2. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
[TBL] [Abstract][Full Text] [Related]
3. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
4. Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.
Gurgenci T; Hardy J; Huggett G; Foster K; Pelecanos A; Greer R; Philip J; Haywood A; Mendis R; Yates P; Good P
Trials; 2024 May; 25(1):293. PubMed ID: 38693590
[TBL] [Abstract][Full Text] [Related]
5. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
6. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD).
Good P; Haywood A; Gogna G; Martin J; Yates P; Greer R; Hardy J
BMC Palliat Care; 2019 Dec; 18(1):110. PubMed ID: 31810437
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol - an effective analgesic for toothache?
Murphy S; Hayes E
Evid Based Dent; 2024 Jun; 25(2):100-101. PubMed ID: 38649735
[TBL] [Abstract][Full Text] [Related]
9. Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain.
Pike CK; Kim M; Schnitzer K; Mercaldo N; Edwards R; Napadow V; Zhang Y; Morrissey EJ; Alshelh Z; Evins AE; Loggia ML; Gilman JM
BMJ Open; 2022 Sep; 12(9):e063613. PubMed ID: 36123113
[TBL] [Abstract][Full Text] [Related]
10. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
Boehnke KF; Gagnier JJ; Matallana L; Williams DA
J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
[TBL] [Abstract][Full Text] [Related]
11. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.
van de Donk T; Niesters M; Kowal MA; Olofsen E; Dahan A; van Velzen M
Pain; 2019 Apr; 160(4):860-869. PubMed ID: 30585986
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing.
Narayan AJ; Downey LA; Rose S; Di Natale L; Hayley AC
J Clin Sleep Med; 2024 May; 20(5):753-763. PubMed ID: 38174873
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey.
Boehnke KF; Gagnier JJ; Matallana L; Williams DA
J Pain; 2021 May; 22(5):556-566. PubMed ID: 33400996
[TBL] [Abstract][Full Text] [Related]
14. Cannabis-based medicines and medical cannabis for adults with cancer pain.
Häuser W; Welsch P; Radbruch L; Fisher E; Bell RF; Moore RA
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014915. PubMed ID: 37283486
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
Mlost J; Bryk M; Starowicz K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
[TBL] [Abstract][Full Text] [Related]
16. Oral Cannabidiol for Seborrheic Dermatitis in Patients With Parkinson Disease: Randomized Clinical Trial.
Weber I; Zagona-Prizio C; Sivesind TE; Adelman M; Szeto MD; Liu Y; Sillau SH; Bainbridge J; Klawitter J; Sempio C; Dunnick CA; Leehey MA; Dellavalle RP
JMIR Dermatol; 2024 Mar; 7():e49965. PubMed ID: 38466972
[TBL] [Abstract][Full Text] [Related]
17. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N
BMC Psychiatry; 2024 Mar; 24(1):175. PubMed ID: 38433233
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.
van der Flier FE; Kwee CMB; Cath DC; Batelaan NM; Groenink L; Duits P; van der Veen DC; van Balkom AJLM; Baas JMP
BMC Psychiatry; 2019 Feb; 19(1):69. PubMed ID: 30760241
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.
McGuire P; Robson P; Cubala WJ; Vasile D; Morrison PD; Barron R; Taylor A; Wright S
Am J Psychiatry; 2018 Mar; 175(3):225-231. PubMed ID: 29241357
[TBL] [Abstract][Full Text] [Related]
20. Can cannabidiol have an analgesic effect?
Kulesza B; Mazurek M; Kurzepa J
Fundam Clin Pharmacol; 2024 Feb; 38(1):33-41. PubMed ID: 37584368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
